🇺🇸 FDA
Patent

US 10421952

Mutant organophosphorus acid anhydrolase enzymes having increased catalytic efficiency on V-agents

granted A61KA61K38/00

Quick answer

US patent 10421952 (Mutant organophosphorus acid anhydrolase enzymes having increased catalytic efficiency on V-agents) held by The United States of America as represented by the Secretary of the Army expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/00